ASTM E3002 - 15 - Standard Practice for Assessing the Comparative Efficacy of Products Used for the Decontamination of Chemical Warfare Agents (CWAs) on Skin

ASTM E3002 - 15

Standard Practice for Assessing the Comparative Efficacy of Products Used for the Decontamination of Chemical Warfare Agents (CWAs) on Skin

Status : Current   Published : June 2015

Format
PDF

Format
HARDCOPY



1.1 This practice establishes an in-vivo method for assessing the comparative efficacy of products used for the decontamination of chemical warfare agents (CWAs) on the skin.

1.2 This practice provides a quantitative efficacy comparison of different skin decontamination products.

1.3 To minimize the number of animals used, this in-vivo practice should be performed only after rigorous in-vitro studies of the candidate decontaminant, which can show the implied claims including chemical neutralization, decontamination studies on surfaces and appropriate testing such as cytotoxicity.

1.4 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

1.5  This standard does not purport to address all of the safety concerns, if any, associated with the use of decontamination products or CWAs. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.




Standard NumberASTM E3002 - 15
TitleStandard Practice for Assessing the Comparative Efficacy of Products Used for the Decontamination of Chemical Warfare Agents (CWAs) on Skin
StatusCurrent
Publication Date15 June 2015
Normative References(Required to achieve compliance to this standard)No other standards are normatively referenced
Informative References(Provided for Information)No other standards are informatively referenced
Descriptors Acetylcholinesterase, Chemical Warfare Agents (CWAs), Decontamination and neutralization, GA Tabun, GB Sarin, GD Soman, GF Cyclohexyl Sarin, HD Mustard, in-vitro, in-vivo, LDinf50/inf, Nerve agents, Neutralization, Protective ratio, Organophosphate (OP), Skin, VX Nerve Agent
ICS13.200
PublisherASTM
FormatA4
DeliveryYes
Pages5
File Size79 KB
Price£40.00


 Your basket
Your basket is empty

Multi-user access to over 3,500 medical device standards, regulations, expert commentaries and other documents


Worldwide Standards
We can source any standard from anywhere in the world


BSOL

The faster, easier way to work with standards


Collaborate, Innovate, Accelerate.